LPL Financial LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$99,479
+33.3%
51,8120.0%0.00%
Q2 2023$74,609
-32.1%
51,812
-1.0%
0.00%
Q1 2023$109,855
+55.4%
52,312
-16.4%
0.00%
Q4 2022$70,707
-30.0%
62,573
+0.8%
0.00%
Q3 2022$101,000
+31.2%
62,073
+6.0%
0.00%
Q2 2022$77,000
-18.1%
58,5340.0%0.00%
Q1 2022$94,000
-5.1%
58,534
+22.9%
0.00%
Q4 2021$99,000
-48.4%
47,634
-3.8%
0.00%
Q3 2021$192,000
+15.0%
49,534
-4.8%
0.00%
Q2 2021$167,000
+377.1%
52,034
+219.5%
0.00%
Q1 2021$35,000
-10.3%
16,284
-7.4%
0.00%
Q4 2020$39,000
-22.0%
17,584
-5.4%
0.00%
Q3 2020$50,000
-41.9%
18,584
-34.2%
0.00%
Q2 2020$86,000
+65.4%
28,233
+6.5%
0.00%
Q1 2020$52,000
-31.6%
26,5110.0%0.00%
Q4 2019$76,000
-21.6%
26,5110.0%0.00%
Q3 2019$97,000
-21.1%
26,511
-10.8%
0.00%
Q2 2019$123,000
-24.5%
29,711
-6.8%
0.00%
Q1 2019$163,000
+64.6%
31,877
+10.4%
0.00%
Q4 2018$99,000
-44.7%
28,877
-3.1%
0.00%
Q3 2018$179,000
-8.7%
29,793
-3.2%
0.00%
-100.0%
Q2 2018$196,000
+75.0%
30,793
+30.5%
0.00%
Q1 2018$112,00023,5930.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders